JP Morgan Maintains Neutral on BioNTech, Raises Price Target to $93

Benzinga · 2d ago
JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Neutral and raises the price target from $92 to $93.